Biodegradable polymer nanocapsules containing a sunscreen agent:: preparation and photoprotection

被引:139
作者
Alvarez-Román, R
Barré, G
Guy, RH
Fessi, H
机构
[1] Univ Geneva, Ctr Interuniv Rech & Enseignement, CH-74166 Geneva, Switzerland
[2] Univ Lyon, Ctr Interuniv Rech & Enseignement, F-74166 Lyon, France
[3] Univ Lyon 1, CNRS, UMR 5007, F-69365 Lyon, France
[4] Univ Geneva, Sch Pharm, Geneva, Switzerland
关键词
nanocapsules; solvent displacement; biodegradable polymers; sunscreen; photoprotection;
D O I
10.1016/S0939-6411(01)00188-6
中图分类号
R9 [药学];
学科分类号
1007 [药学];
摘要
Biodegradable polymer nanocapsules containing the lipophilic sunscreen, Parsol MCX (OMC), as the oil core were prepared by solvent displacement. We investigated the influence of polysorbate 85 (P-85) and poloxamer 188 (P-188) as stabilizing agents, the OMC loading capacity and the photoprotective potential of the formulations. The formation of nanocapsules is probably due to an interfacial instability arising from rapid diffusion of the solvent across the interface. The effectiveness of the stabilizing agents was attributed to their ability to inhibit coalescence during solvent diffusion. P-85 was a better stabilizer of poly (epsilon -Caprolactone)-nanocapsules than P-188. The OMC loading capacity was high (99 +/- 1% of OMC initial concentration). The in vitro release of OMC-nanocapsules is governed by hydrophobicity and crystallinity of the polymer and by the high lipophilicity of the drug. The OMC-nanocapsules provided partial protection against UV-induced erythema, in a manner significantly better than a conventional gel. (C) 2001 Published by Elsevier Science B.V.
引用
收藏
页码:191 / 195
页数:5
相关论文
共 18 条
[1]
ALLEMANN E, 1993, EUR J PHARM BIOPHARM, V39, P173
[2]
BARRE G, 1992, 14590 U PAR
[3]
FALLOUH NA, 1986, INT J PHARM, V28, P125
[4]
NANOCAPSULE FORMATION BY INTERFACIAL POLYMER DEPOSITION FOLLOWING SOLVENT DISPLACEMENT [J].
FESSI, H ;
PUISIEUX, F ;
DEVISSAGUET, JP ;
AMMOURY, N ;
BENITA, S .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1989, 55 (01) :R1-R4
[5]
FESSI H, 1988, Patent No. 2
[6]
Percutaneous absorption of sunscreens through micro-Yucatan pig skin in vitro [J].
Gupta, VK ;
Zatz, JL ;
Rerek, M .
PHARMACEUTICAL RESEARCH, 1999, 16 (10) :1602-1607
[7]
POLY(DL-LACTIDE) NANOCAPSULES CONTAINING DICLOFENAC .1. FORMULATION AND STABILITY STUDY [J].
GUTERRES, SS ;
FESSI, H ;
BARRATT, G ;
DEVISSAGUET, JP ;
PUISIEUX, F .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1995, 113 (01) :57-63
[8]
KENNETH KL, 1992, J INVEST DERMATOL, V98, P720
[9]
Preparation and in vitro evaluation of biodegradable poly(epsilon-caprolactone-co-D,L lactide)(X-Y) devices containing trypanocidal drugs [J].
Lemmouchi, Y ;
Schacht, E .
JOURNAL OF CONTROLLED RELEASE, 1997, 45 (03) :227-233
[10]
Stability study of nanoparticles of poly(epsilon-caprolactone), poly(D,L-lactide) and poly(D,L-lactide-co-glycolide) [J].
Lemoine, D ;
Francois, C ;
Kedzierewicz, F ;
Preat, W ;
Hoffman, M ;
Maincent, P .
BIOMATERIALS, 1996, 17 (22) :2191-2197